preclamol has been researched along with butaclamol in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Contreras, PC; Dilworth, VM; Farah, JM; Gray, NM; Iyengar, S; Mick, SJ; Rao, TS; Wood, PL | 1 |
| Carlsson, A; Clark, D; Hjorth, S | 1 |
| Billingsley, ML; Roth, RH | 1 |
| Sonsalla, PK; Terleckyj, I | 1 |
| Fu, D; Javitch, JA; Lin, H; Strange, PG; Wilson, J | 1 |
5 other study(ies) available for preclamol and butaclamol
| Article | Year |
|---|---|
(+) 3-[3-hydroxyphenyl-N-(1-propyl) piperidine] selectively differentiates effects of sigma ligands on neurochemical pathways modulated by sigma receptors: evidence for subtypes, in vivo.
Topics: Adrenocorticotropic Hormone; Animals; Brain; Butaclamol; Cerebellum; Corpus Striatum; Cyclic GMP; Dopamine; Dopamine Agents; Male; Mice; Pentazocine; Phenazocine; Piperidines; Prolactin; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid; Receptors, sigma | 1991 |
Lack of functional evidence for the involvement of sigma opiate receptors in the actions of the 3-PPP enantiomers on central dopaminergic systems: discrepancies between in vitro and in vivo observations.
Topics: Animals; Butaclamol; Corpus Striatum; Dopamine; Limbic System; Male; Motor Activity; Pentazocine; Piperidines; Prolactin; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, sigma; Reserpine; Stereoisomerism | 1985 |
Dopamine agonists stimulate protein carboxylmethylation in striatal synaptosomes.
Topics: Animals; Apomorphine; Butaclamol; Corpus Striatum; Dopamine; Hydroxydopamines; In Vitro Techniques; Male; Nerve Tissue Proteins; Piperidines; Potassium; Protein Methyltransferases; Protein O-Methyltransferase; Rats; Rats, Inbred Strains; S-Adenosylhomocysteine; S-Adenosylmethionine; Synaptosomes | 1982 |
The sigma receptor ligand (+/-)-BMY 14802 prevents methamphetamine-induced dopaminergic neurotoxicity via interactions at dopamine receptors.
Topics: Animals; Anticonvulsants; Antipsychotic Agents; Brain Diseases; Butaclamol; Carbazoles; Dizocilpine Maleate; Dopamine; Dopamine Agents; Drug Interactions; Drug Synergism; Guanidines; Ligands; Male; Methamphetamine; Mice; MPTP Poisoning; Neostriatum; Piperidines; Psychotropic Drugs; Pyrimidines; Receptors, Dopamine; Receptors, sigma; Stereoisomerism; Tyrosine 3-Monooxygenase | 1994 |
Mechanisms of inverse agonism of antipsychotic drugs at the D(2) dopamine receptor: use of a mutant D(2) dopamine receptor that adopts the activated conformation.
Topics: 1-Methyl-3-isobutylxanthine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Apomorphine; Binding, Competitive; Bromocriptine; Butaclamol; Chlorpromazine; CHO Cells; Clozapine; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; GTP-Binding Proteins; Haloperidol; Humans; Macromolecular Substances; Mutagenesis, Site-Directed; Phenethylamines; Piperidines; Protein Binding; Protein Conformation; Radioligand Assay; Receptors, Dopamine D2; Recombinant Fusion Proteins; Sodium; Spiperone; Structure-Activity Relationship; Sulpiride; Transfection; Tyramine | 2001 |